23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
3.760
-0.040 (-1.05%)
Aug 15, 2025, 4:00 PM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $103.56 million as of August 15, 2025. Its market cap has decreased by -48.84% in one year.
Market Cap
103.56M
Enterprise Value
90.83M
Revenue
174.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.76
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 103.56M, a decrease of -83.38%. That is a compound annual growth rate of -31.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 103.56M | 23.33% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |